- Filed
- Feb 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jan 29, 2025 | 29.92M sh |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $34.62M |
| Long Term Debt | Q2 2025 · Jun 30, 2024 | $50.66M |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $3.57M |
| Short Term Debt | Q2 2025 · Jun 30, 2024 | $3.57M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $4.71M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $4.11M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $78.55M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $79.21M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $163.41M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $162.5M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $344.55M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $348.8M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 30.04M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 29.95M sh |
| Dividends Paid | Q2 2025 · Dec 31, 2023 | $2.83M |
| Capex | Q2 2025 · Dec 31, 2023 | $3.35M |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $19.87M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.20 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.47 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.20 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.48 |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $23.72M |
| Sga Expense restated | Q2 2025 · Dec 31, 2023 | $49.28M |
| Net Income | Q2 2025 · Dec 31, 2023 | $5.91M |
| Net Income | Q2 2025 · Dec 31, 2023 | $13.93M |
| Net Income | Q2 2025 · Sep 30, 2023 | $8.03M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $7.82M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $18.85M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $31.54M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $68.13M |
| Cost Of Revenue restated | Q2 2025 · Dec 31, 2023 | $77.47M |
| Cost Of Revenue restated | Q2 2025 · Dec 31, 2023 | $164.32M |